Company Valuation: Biosynex

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 151.6 289.9 141 85.85 18.51 11.17
Change - 91.16% -51.35% -39.13% -78.44% -39.63%
Enterprise Value (EV) 1 130.6 193.2 105.9 125.7 71.44 64.36
Change - 47.93% -45.16% 18.6% -43.14% -9.91%
P/E 5.44x 2.63x 9.08x -2.42x -0.43x -0.19x
PBR 2.29x 1.62x 0.87x 0.72x 0.23x 0.3x
PEG - 0x -0.1x 0x -0x 0x
Capitalization / Revenue 0.99x 0.76x 0.72x 0.92x 0.18x 0.12x
EV / Revenue 0.85x 0.5x 0.54x 1.35x 0.71x 0.68x
EV / EBITDA 2.84x 1.36x 2.28x -4.21x -3.22x -4.72x
EV / EBIT 2.86x 1.37x 2.72x -3.48x -2.59x -2.47x
EV / FCF 7.61x 2.62x -3.59x -2.83x -43.6x 4.54x
FCF Yield 13.1% 38.1% -27.9% -35.3% -2.29% 22%
Dividend per Share 2 0.2 2 - - - -
Rate of return 1.2% 7.6% - - - -
EPS 2 3.05 10.01 1.52 -3.45 -4.03 -3.159
Distribution rate 6.56% 20% - - - -
Net sales 1 153.9 382.5 196.6 92.98 101.2 95.19
EBITDA 1 46.02 141.8 46.49 -29.82 -22.16 -13.64
EBIT 1 45.73 140.7 38.88 -36.15 -27.53 -26.05
Net income 1 31.37 104 15.66 -36.95 -43.33 -58.22
Net Debt 1 -21.07 -96.72 -35.09 39.8 52.94 53.19
Reference price 2 16.6000 26.3200 13.8000 8.3500 1.7200 0.5960
Nbr of stocks (in thousands) 9,135 11,014 10,220 10,281 10,761 18,748
Announcement Date 4/21/21 4/25/22 4/28/23 4/30/24 4/30/25 5/7/26
1EUR in Million2EUR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 19.24M
-49.06x16.05x-116.97x-.--% 21.15B
17.75x1.97x8.33x1.44% 9.83B
22.84x4.28x12.28x - 6.58B
-56.21x8.65x-73.62x-.--% 5.79B
133.73x5.08x28.33x-.--% 5.65B
20.15x6.92x15.67x2.85% 5.46B
21.4x3.55x11.02x1.75% 4.25B
16.13x - - 3.99% 2.71B
Average 15.84x 6.64x -16.42x 1.43% 6.83B
Weighted average by Cap. -0.61x 8.83x -41.64x 0.88%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA